---
title: "Contract for the provision of Histopathology reporting, Urology and Breast MDT"
ocid: "ocds-h6vhtk-03e01b"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03e01b"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-03e01b.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-03e01b.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "GREAT WESTERN HOSPITALS NHS FOUNDATION TRUST"
published: "2023-07-10"
---

# Contract for the provision of Histopathology reporting, Urology and Breast MDT

Buyer: GREAT WESTERN HOSPITALS NHS FOUNDATION TRUST  
Current stage: Award  
OCID: ocds-h6vhtk-03e01b

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03e01b)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-03e01b.json)

## Summary

The Great Western Hospitals NHS Foundation Trust has awarded a contract for the provision of Histopathology reporting, Urology and Breast MDT to Poundbury Cancer Centre Ltd. The contract, classified under pathology services, was a direct award procedure without prior publication of a call for competition. The contract value is £420,000, signed on 9th July 2023. The contract location is Poundbury Cancer Institute in Dorchester, United Kingdom.

This tender presents a business growth opportunity for companies involved in pathology services. Suppliers specialising in Histopathology reporting, Urology, and Breast MDT services would be well-suited to compete in similar tender processes. The procurement process, carried out by the Great Western Hospitals NHS Foundation Trust, involved a limited Award procedure to maintain service continuity. Companies with experience in such specialized medical services may find lucrative opportunities in collaborating with public healthcare institutions for similar contracts.

## Notice

A contract for the provision of Histopathology reporting, Urology and Breast MDT

### Lot Information

Lot 1

A direct award to Poundbury Cancer Institute (PCI) for the supply of Histopathology reporting, Urology and Breast MDT

### Procurement Information

Great Western Hospitals NHS Foundation Trust (GWH) intends to award a contract under Regulation 32(2)(b)(ii), to Poundbury Cancer Institute (PCI) in respect of Histopathology reporting, Urology and Breast MDT, for a period of one year, with an option to extend for a further period of one year. This to maintain continuation of service delivery while the separate contract end dates for this requirement at GWH and Salisbury NHS Foundation Trust (SFT) are aligned and the collaborative requirement is re-tendered as a BSW Procurement Alliance collaborative contract, to ensure greater efficiency when procuring services. PCI is the incumbent supplier and the new contract will ensure that the current service is maintained until the re-tender is complete, without risk to patient care or the accumulation of cost and resource pressures. To award another supplier a temporary arrangement of this nature may result in the following:

Trust Turnaround Times and Patient Care: Variations in turnaround while new systems are set up. Currently PCI routes for reporting are established and consistent. Risking this could lead to increased Turnaround and delays to the diagnosis, and in turn treatment, of patients within the Trust 

Packaging and Transport: new routes of transport for slides and blocks have to be set up. This will add extra pressure to the departments' sendaways team. Packaging requirements may also vary, leading to additional costs of purchase, and increased time to carry out alternative packaging requirements. 

IT and Report Transcription: The reporting of cases by PCI is an established process, and the departments secretarial staff are familiar with the process of transcribing the received reports onto the LIMS. A new provider could lead to additional reporting processes, or access may be required to additional external IT systems, increasing the workload of the secretaries. 

Additional Testing Requirements: A new provider may wish to introduce new tests (such as Immunohistochemical markers) not routinely performed within the department. This will increase the cost as these may have to be outsourced or will have to be worked up and verified in house, adding to the department's workload. Currently the requirements of PCI are known to the department and requesting additional work is an established process. 

Documentation: Changing provider will result in numerous document updates that will add to the department's ongoing quality work. 

Accreditation: UKAS, would have to be informed of any changes in provider, and any tests that they require that are not on our schedule would have to be reported as unaccredited tests.

GWH has reviewed the factors described and considers that for the technical reasons listed, awarding PCI is the only reasonable solution as it mitigates the risk of a detrimental effect on the service and the accumulation of preventable cost and resource pressures until the re-tender of the collaborative contract across the two Trusts. GWH will observe a 10 day standstill from the date of this notice before entering into a contract with Poundbury Cancer Institute (PCI).

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/019565-2023 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 10 Jul 2023 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 8 Jul 2023 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £420,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | GREAT WESTERN HOSPITALS NHS FOUNDATION TRUST |
| Locality | SWINDON |
| Post town | Swindon |
| Postcode | SN3 6BB |
| Country | England |
| ITL 1 | TLK South West (England) |
| ITL 2 | TLK7 Gloucestershire and Wiltshire |
| ITL 3 | TLK71 Swindon |
| Local authority | Swindon |
| Electoral ward | Ridgeway |
| Westminster constituency | East Wiltshire |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | POUNDBURY CANCER CENTRE |

## CPV Codes

### Divisions

- 85 - Health and social work services

### Codes

- 85111800 - Pathology services

## Release History

- 10 Jul 2023 at 07:54 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/019565-2023

## Notice URLs

- https://www.gwh.nhs.uk/
- https://www.salisbury.nhs.uk/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03e01b. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-03e01b.json.